These findings suggest that the enhancement of tumorigenicity in Bit1 knockdown cells is in part due to reduced basal apoptosis and are in agreement with previous published data showing strong inhibition of breast tumor xenograft growth in vivo by ectopic Bit1 CDD treatment [19]. Here, PTRH2 is linked to breast neoplasm.